Medical Marijuana, Inc. Subsidiary HempMeds® Welcomes X Games World Record-Holding Skateboarder Italo Penarrubia as Newest Brand Ambassador

MJNA

Medical Marijuana, Inc. subsidiary HempMeds® welcomes world record breaking skateboarder Italo Penarrubia from X Games as a brand ambassador

SAN DIEGO, March 30, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first US publicly traded cannabis company to introduce the world’s first cannabis-derived nutraceuticals, brands and supply chains, announced today that it is its subsidiary HempMeds® proud to welcome X Games world record skateboarders Italo Penarrubia as the newest brand ambassador.

“We are very excited to have Penarrubia as part of our team and it is heartwarming to know how much our products have helped him over the years. We believe his support and recognition will help us, athletes and the wider community Educate the public on the health and health benefits of hemp-based cannabidiol (CBD) products, “said Raul Elizalde, CEO of HempMeds®.

Penarrubia is a renowned skateboarder and has competed in several X Games competitions, including his last appearance at X Games Minneapolis in 2019. At the 2017 X Games in Minneapolis, he set a world record for the highest SKB Big Air height ever at the X games. After several years training in the United States, Penarrubia recently moved back to Brazil to pursue his career and raise his family.

“I have been using HempMeds CBD products for years to aid recovery after long days of training,” said Penarrubia. “My goal is to fill the knowledge gap for athletes around the world who might benefit from using CBD but are afraid or unsure how to use the products.”

To learn more about HempMeds®, visit the company online at www.hempmedspx.com.

About HempMeds®
HempMeds® was founded in 2012 and was the first to introduce cannabidiol (CBD) oil products based on hemp in the United States. As a subsidiary of Medical Marijuana, Inc., HempMeds is the exclusive distributor for premium brands such as Real Scientific Hemp Oil ™ and Dixie Botanicals® and operates in all 50 states and 40 countries. HempMeds® is the only company whose CBD products are listed in the Prescribers’ Digital Reference (PDR). It is the only company invited to speak with the World Health Organization and the FDA about the benefits of CBD, and one of the first to be certified by the U.S. Hemp Agency. To learn more, please visit www.hempmedspx.com.

The story goes on

About Medical Marijuana, Inc.
We are a firsts® company. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct businesses in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®;; a pioneer in sourcing the highest quality legal non-psychoactive cannabis products made from industrial hemp; and a cannabinoid-based clinical research and development of botanical medicines sector led by its pharmaceutical investment companies and partners, including AXIM® Biotechnologies, Inc.. and Kannalife, Inc.. Medical Marijuana, Inc. named one of the top CBD manufacturers by CNBC. Medical Marijuana, Inc. was also the first to obtain historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in developing international markets. The company’s flagship Real scientific hemp oil has been used in several successful clinical trials across Mexico and Brazil to understand its safety and effectiveness.

Medical Marijuana, Inc. is headquartered in San Diego, California. For more information, see OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see the Medical Marijuana, Inc. corporate video, click here.

Shareholders and consumers are also encouraged to do so Buy CBD oil and other products from the Medical Marijuana, Inc. store

Forward disclaimer
This press release may contain certain forward-looking statements and information as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor established by those sections. This material contains statements about expected future events and / or financial results that are forward-looking in nature and are subject to risks and uncertainties. Such forward-looking statements, by definition, involve risks, uncertainties and other factors that could cause the actual results, performance or success of Medical Marijuana, Inc. to differ materially from the statements made herein.

FOOD AND MEDICINE ADMINISTRATIVE DISCLOSURE (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute products that violate United States Controlled Substances Act.

CONTACT:

PR contact:
Kathryn Brown
Account supervisor
CMW Media
Pp. 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
P. (858) 283-4016
Investors@medicalmarijuanainc.com

attachment